Benjamin Cravatt
Equibles does not estimate personal net worth.
About Benjamin Cravatt
Earlier roles on record: Board Member at Kyntra Bio, Inc. (KYNB) until September 30, 2024. Kyntra Bio, Inc. reported in an 8-K filed September 13, 2024 that Benjamin Cravatt resigned as director, effective September 30, 2024.
“On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the "Board") notification of their resignations from the Board of FibroGen, Inc. (the "Company"), effective September 30, 2024.”
Affiliation history
-
2020-08-05–2024-09-30